PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Tarapeutics Science Inc.

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tarapeutics ranks #37,821 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#37,821
of 49,997 US assignees by volume
Top 50%
by Innovation Score (35.1/100)
12.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R37821 · Foreign Corporation #37,821 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 7 grants
  • LOWER-Q #37,821/49,997
  • PHOTO-FINISH Taivex Therapeutics
  • CPC-NARROW A61P · 4 areas
  • INNOV-THIN 35.1/100
  • CLAIMS-RICH 12.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Taivex Therapeutics Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tarapeutics’s 35.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Tarapeutics

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tarapeutics's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Tarapeutics?

Each dot is one of Tarapeutics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tarapeutics’s own 12.6 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Tarapeutics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 6.97.07.077.07.07.1 1015202530 Granted patents (volume) Avg claims / patent Taivex Therapeutics Corporation - 7, 14.29Taivex Therapeuti…Tama Plastic Industry - 7, 18.86Tama Plastic Indu…Tangent Medical Technologies, Inc. - 7, 24.57Tangent MedicalTanous Works, LLC - 7, 16.43Tanous WorksTarpstop, LLC - 7, 18.43TarpstopTascent, Inc. - 7, 18.86TascentTate Consultancy Services Limited - 7, 12.14Tate Consultancy…Taylor-Winfield Technologies, Inc. - 7, 13Taylor-winfieldTarapeutics Science Inc. - 7, 12.57Tarapeutics Scien…
Tarapeutics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tarapeutics's grants concentrate

Tarapeutics Science Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2020. By volume, Tarapeutics sits between Taivex Therapeutics Corporation and Taylor-Winfield Technologies, Inc..

Tarapeutics's three-year grant acceleration

Tarapeutics Science Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Tarapeutics's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tarapeutics holds 7 patents at rank #37,918, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tarapeutics

By rank, the assignees closest to #37,918 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Tarapeutics's primary technology class.

Tarapeutics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 202020242025 4
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Tarapeutics Science Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 14.3%
2024 2 28.6%
2025partial year 4 57.1%

Which technologies does Tarapeutics Science Inc. patent most?

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tarapeutics Science Inc.'s patent record in context - here's where to go next.

  • Tarapeutics Science Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #37,821 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Tarapeutics Science Inc. against Taivex Therapeutics Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.